Zacks Research Estimates CME Group FY2024 Earnings

CME Group Inc. (NASDAQ:CME) – Research analysts at Zacks Research issued their FY2024 earnings per share estimates for CME Group in a report released on Wednesday, November 13th. Zacks Research analyst T. De anticipates that the financial services provider will post earnings of $10.21 per share for the year. The consensus estimate for CME Group’s current full-year earnings is $10.22 per share. Zacks Research also issued estimates for CME Group’s Q4 2025 earnings at $2.56 EPS.

CME Group (NASDAQ:CME) last announced its earnings results on Wednesday, October 23rd. The financial services provider reported $2.68 earnings per share for the quarter, topping the consensus estimate of $2.65 by $0.03. The company had revenue of $1.58 billion during the quarter, compared to analyst estimates of $1.59 billion. CME Group had a net margin of 57.34% and a return on equity of 13.39%. CME Group’s revenue was up 18.4% compared to the same quarter last year. During the same quarter last year, the firm posted $2.25 earnings per share.

Other research analysts have also issued reports about the company. Royal Bank of Canada restated a “sector perform” rating and set a $235.00 price target on shares of CME Group in a research report on Thursday, October 24th. Keefe, Bruyette & Woods lifted their target price on CME Group from $212.00 to $213.00 and gave the company a “market perform” rating in a research report on Thursday, July 25th. Citigroup increased their price target on shares of CME Group from $250.00 to $255.00 and gave the stock a “buy” rating in a research report on Thursday, October 24th. Oppenheimer lifted their price objective on shares of CME Group from $245.00 to $258.00 and gave the company an “outperform” rating in a report on Thursday, October 24th. Finally, JPMorgan Chase & Co. increased their target price on shares of CME Group from $187.00 to $191.00 and gave the stock an “underweight” rating in a report on Thursday, July 25th. Four equities research analysts have rated the stock with a sell rating, seven have given a hold rating and four have assigned a buy rating to the stock. According to MarketBeat, CME Group presently has an average rating of “Hold” and a consensus price target of $224.47.

CME Group Stock Performance

NASDAQ:CME opened at $227.56 on Monday. CME Group has a fifty-two week low of $190.70 and a fifty-two week high of $230.36. The company has a debt-to-equity ratio of 0.09, a quick ratio of 1.02 and a current ratio of 1.02. The company has a 50 day moving average price of $222.80 and a 200 day moving average price of $210.53. The stock has a market capitalization of $82.00 billion, a P/E ratio of 23.93, a PEG ratio of 5.20 and a beta of 0.55.

CME Group Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, December 27th. Stockholders of record on Monday, December 9th will be given a dividend of $1.15 per share. The ex-dividend date is Monday, December 9th. This represents a $4.60 annualized dividend and a dividend yield of 2.02%. CME Group’s dividend payout ratio is currently 48.37%.

Insider Activity

In other CME Group news, Director Martin J. Gepsman sold 400 shares of the company’s stock in a transaction on Monday, November 4th. The shares were sold at an average price of $222.92, for a total value of $89,168.00. Following the completion of the transaction, the director now owns 25,067 shares in the company, valued at $5,587,935.64. This represents a 1.57 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, insider Timothy Francis Mccourt sold 1,374 shares of CME Group stock in a transaction dated Monday, October 28th. The stock was sold at an average price of $227.12, for a total value of $312,062.88. Following the sale, the insider now owns 7,275 shares in the company, valued at $1,652,298. This trade represents a 15.89 % decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 15,621 shares of company stock worth $3,441,063. 0.30% of the stock is currently owned by insiders.

Hedge Funds Weigh In On CME Group

A number of hedge funds have recently modified their holdings of the business. Ontario Teachers Pension Plan Board acquired a new position in CME Group in the first quarter valued at $665,000. UniSuper Management Pty Ltd grew its stake in shares of CME Group by 217.1% in the 1st quarter. UniSuper Management Pty Ltd now owns 9,240 shares of the financial services provider’s stock valued at $1,989,000 after purchasing an additional 6,326 shares during the last quarter. Atlanta Consulting Group Advisors LLC acquired a new position in shares of CME Group in the first quarter valued at approximately $525,000. Bessemer Group Inc. raised its stake in shares of CME Group by 416.7% during the first quarter. Bessemer Group Inc. now owns 21,365 shares of the financial services provider’s stock worth $4,599,000 after purchasing an additional 17,230 shares during the last quarter. Finally, Burgundy Asset Management Ltd. lifted its holdings in shares of CME Group by 49.0% during the first quarter. Burgundy Asset Management Ltd. now owns 680,434 shares of the financial services provider’s stock worth $146,491,000 after purchasing an additional 223,709 shares during the period. 87.75% of the stock is currently owned by hedge funds and other institutional investors.

CME Group Company Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.